Arcadia Biosciences, Inc. (RKDA)
$7.87
+0.12 (+1.55%)
Rating:
Recommendation:
Neutral
| Symbol | RKDA |
|---|---|
| Price | $7.87 |
| Beta | 0.106 |
| Volume Avg. | 0.16M |
| Market Cap | 4.849M |
| Shares () | - |
| 52 Week Range | 6.69-83.6 |
| 1y Target Est | - |
| DCF Unlevered | RKDA DCF -> | |
|---|---|---|
| DCF Levered | RKDA LDCF -> | |
| ROE | -69.78% | Strong Sell |
| ROA | -57.30% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 37.72% | Neutral |
| P/E | -0.22 | Neutral |
| P/B | 0.19 | Neutral |
Latest RKDA news
About
Download (Excel)Mr. Stanley E. Jacot Jr.
Basic Materials
Agricultural Inputs
NASDAQ Capital Market
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.